Options
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
Journal
Cancer medicine
Journal Volume
12
Journal Issue
7
End Page
7794
Date Issued
2023-04
Author(s)
Ryu, Min-Hee
Lee, Kyung Hee
Shen, Lin
Yoo, Changhoon
Hong, Young Seon
Park, Young Iee
Yang, Sung Hyun
Shin, Dong Bok
Zang, Dae Young
Kang, Won Ki
Chung, Ik-Joo
Kim, Yeul Hong
Ryoo, Baek-Yeol
Nam, Byung-Ho
Park, Young Soo
Kang, Yoon-Koo
Abstract
In this randomized phase II study, we evaluated the efficacy and safety of sorafenib in combination with capecitabine and cisplatin (XP) as first-line chemotherapy in advanced gastric cancer.
Subjects
VEGF; capecitabine; chemotherapy; cisplatin; gastric cancer; sorafenib
Type
journal article